Improved refractory wound healing with administration of acidic fibroblast growth factor in diabetic rats

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 396-403

  Xie, Liyun ^a   Zhang, Meiling ^a   Dong, Baijun ^b   Guan, Mimi ^a   Lu, Meifei ^a   Huang, Zhifeng ^a   Gao, Hongchang ^a   Li, Xiaokun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

AFGF; Diabetic ulcer; Immunohistochemistry; Pathological section

Indexed keywords

CYCLINE; FIBROBLAST GROWTH FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ULCER; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SKIN FIBROBLAST; SKIN ULCER; WOUND HEALING;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLAST GROWTH FACTOR 1; IMMUNOHISTOCHEMISTRY; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SKIN ULCER; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 80052760765     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.016     Document Type: Article

References (26)

1. Itoh N., Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004, 20:563-569.
2. Jeffcoate W.J., Harding K.G. Diabetic foot ulcers. Lancet 2003, 361:1545-1551.
3. Feldman B., Poueymirou W., Papaioannou V.E., DeChiara T.M., Goldfarb M. Requirement of FGF-4 for postimplantation mouse development. Science 1995, 267:246-249.
4. Nakada T., Saito Y., Chikenji M., Koda S., Higuchi M., Kawata K., et al. Therapeutic outcome of hyperbaric oxygen and basic fibroblast growth factor on intractable skin ulcer in legs: preliminary report. Plast Reconstr Surg 2006, 117:646-651. discussion 52-3.
5. Thangarajah H., Yao D., Chang E.I., Shi Y., Jazayeri L., Vial I.N., et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A 2009, 106:13505-13510.
6. Eming S.A., Hammerschmidt M., Krieg T., Roers A. Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol 2009, 20:517-527.
7. Yoon C.S., Jung H.S., Kwon M.J., Lee S.H., Kim C.W., Kim M.K., et al. Sonoporation of the minicircle-VEGF(165) for wound healing of diabetic mice. Pharm Res 2009, 26:794-801.
8. Wei W., Liu Q., Tan Y., Liu L., Li X., Cai L. Oxidative stress, diabetes, and diabetic complications. Hemoglobin 2009, 33:370-377.
9. Kim H.J., Jung H.H., Lee S.H. Expression of acidic fibroblast growth factor and basic fibroblast growth factor in nasal polyps. Acta Otolaryngol 2006, 126:600-605.
10. Cao W., Li F., Steinberg R.H., Lavail M.M. Development of normal and injury-induced gene expression of aFGF, bFGF, CNTF, BDNF, GFAP and IGF-I in the rat retina. Exp Eye Res 2001, 72:591-604.
11. Wiedlocha A. Activation of the cell proliferation program by acidic fibroblast growth factor (aFGF). Postepy Hig Med Dosw 1999, 53:277-289.
12. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117:1219-1222.
13. Wang W., Lin S., Xiao Y., Huang Y., Tan Y., Cai L., et al. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sci 2008, 82:190-204.
14. Mellin T.N., Cashen D.E., Ronan J.J., Murphy B.S., Disalvo J., Thomas K.A. Acidic fibroblast growth-factor accelerates dermal wound-healing in diabetic mice. J Invest Dermatol 1995, 104:850-855.
15. Li H., Ni Y., Su M., Qiu Y., Zhou M., Qiu M., et al. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. J Proteome Res 2007, 6:1364-1370.
16. Xie T., Niu Y., Ge K., Lu S. Regulation of keratinocyte proliferation in rats with deep, partial-thickness scald: modulation of cyclin D1-cyclin-dependent kinase 4 and histone H1 kinase activity of M-phase promoting factor. J Surg Res 2008, 147:9-14.
17. Musalmah M., Nizrana M.Y., Fairuz A.H., NoorAini A.H., Azian A.L., Gapor M.T., et al. Comparative effects of palm vitamin E and alpha-tocopherol on healing and wound tissue antioxidant enzyme levels in diabetic rats. Lipids 2005, 40:575-580.
18. Zcharia E., Zilka R., Yaar A., Yacoby-Zeevi O., Zetser A., Metzger S., et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J 2005, 19:211-221.
19. Wong A.K., Schonmeyr B., Singh P., Carlson D.L., Li S., Mehrara B.J. Histologic analysis of angiogenesis and lymphangiogenesis in acellular human dermis. Plast Reconstr Surg 2008, 121:1144-1152.
20. Yamaguchi R., Takami Y., Yamaguchi Y., Shimazaki S. Bone marrow-derived myofibroblasts recruited to the upper dermis appear beneath regenerating epidermis after deep dermal burn injury. Wound Repair Regen 2007, 15:87-93.
21. Wu Y., Chen L., Scott P.G., Tredget E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
22. Ammann A.J., Beck L.S., DeGuzman L., Hirabayashi S.E., Lee W.P., McFatridge L., et al. Transforming growth factor-beta. Effect on soft tissue repair. Ann N Y Acad Sci 1990, 593:124-134.
23. Nall A.V., Brownlee R.E., Colvin C.P., Schultz G., Fein D., Cassisi N.J., et al. Transforming growth factor beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol 1996, 122:171-177.
24. Schabort E.J., van der Merwe M., Loos B., Moore F.P., Niesler C.U. TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. Exp Cell Res 2009, 315:373-384.
25. Smiell J.M., Wieman T.J., Steed D.L., Perry B.H., Sampson A.R., Schwab B.H. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999, 7:335-346.
26. Loot M.A., Kenter S.B., Au F.L., van Galen W.J., Middelkoop E., Bos J.D., et al. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 2002, 81:153-160.